Scientists Identify New Genetic Risk Factors for Fibromyalgia, Offering Hope for Better Treatments
A major study has identified new genetic risk factors associated with fibromyalgia, a chronic pain disorder that affects millions. Researchers examined the DNA of over two million individuals, confirming that fibromyalgia is linked to problems in pain processing. This study, involving experts from institutions like King’s College London, analyzed genetic differences in people with and without the condition, identifying 26 genome regions affecting fibromyalgia risk. The findings suggest a biological basis for the disorder, challenging the long-held belief that it is purely psychological. The study also found a connection between fibromyalgia and the gene HTT, which is linked to Huntington’s disease, suggesting potential new treatment pathways. 
